Global Handheld Surgical Instruments Market Segmentation, By Product (Forceps, Retractors, Dilators, Graspers, Scalpels, Cannulas, Dermatomes, Trocars, and Others), Application (Neurosurgery, Cardiovascular, Orthopaedic, Plastic and Reconstructive Surgery, Obstetrics and Gynaecology, Wound Care, Audiology, Thoracic Surgery, Urology, and Others), End User (Hospitals, Clinics, Ambulatory Surgical Centres, and Others) – Industry Trends and Forecast to 2031
Handheld Surgical Instruments Market Analysis
The global handheld surgical instruments market is experiencing significant growth, driven by advancements in surgical technology and increasing healthcare expenditures. These instruments, essential for various surgical procedures, encompass a wide range of tools including forceps, scalpels, retractors, and dilators. As surgical techniques evolve, there is a growing demand for precision and efficiency, leading to innovations such as ergonomic designs and enhanced materials that improve usability and outcomes. Technological advancements have also introduced smart handheld surgical instruments equipped with sensors and connectivity features, enabling real-time monitoring and data collection during surgeries. These innovations not only enhance the surgical process but also contribute to better patient outcomes and safety. Additionally, the rise in minimally invasive surgeries is boosting the demand for specialized handheld instruments designed for these procedures, as they minimize recovery time and reduce the risk of complications. With a growing emphasis on advanced healthcare technologies, regions such as North America and Asia-Pacific are leading the market. As hospitals and surgical centers invest in state-of-the-art equipment, the global handheld surgical instruments market is poised for continued growth, offering new opportunities for manufacturers and healthcare providers alike.
Handheld Surgical Instruments Market Size
The global handheld surgical instruments market size was valued at USD 5.29 billion in 2023 and is projected to reach USD 8.97 billion by 2031, with a CAGR of 6.81% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Handheld Surgical Instruments Market Trends
“Rising Adoption of Ergonomic Designs”
The handheld surgical instruments market is witnessing a significant trend toward the adoption of ergonomic designs, enhancing both the functionality and comfort of surgical tools. These advancements are crucial as they directly impact the efficiency and precision of surgical procedures, ultimately improving patient outcomes. For instance, companies such as Medtronic have developed ergonomic scalpels and forceps that reduce hand fatigue for surgeons during lengthy operations. This focus on ergonomics is driven by the increasing recognition of the importance of reducing strain on healthcare professionals, leading to higher-quality surgical performance. Additionally, as the demand for minimally invasive surgeries rises, instruments designed with ergonomics in mind are becoming essential, allowing surgeons to navigate complex procedures with greater dexterity. By prioritizing ergonomic innovation, the handheld surgical instruments market is enhancing surgical efficacy and addressing the well-being of medical professionals, thereby driving growth in this segment.
Report Scope and Handheld Surgical Instruments Market Segmentation
|
Attributes
|
Handheld Surgical Instruments Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Bausch Health Companies Inc. (Canada), B. Braun SE (Germany), Biotronik (Germany), Medtronic (Ireland), BD (U.S.), Boston Scientific Corporation (U.S.), Abbott (U.S.), Integra LifeSciences Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Zimmer Biomet (U.S.), CooperSurgical, Inc. (U.S.), Smith+Nephew (U.K.), TOPCON CORPORATION (Japan), Novartis AG (Switzerland), Danaher (U.S.), Aspen Surgical Products, Inc. (U.S.), Thompson Surgical (U.S.), and KLS Martin Group (Germany)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Handheld Surgical Instruments Market Definition
Handheld surgical instruments are tools specifically designed for use by surgeons during surgical procedures. Handheld surgical instruments are essential for performing precise tasks, such as cutting, grasping, holding, and manipulating tissues, enabling surgeons to conduct operations effectively and safely. Their design is tailored to provide optimal control, stability, and ease of use, often incorporating ergonomic features to reduce strain on the surgeon's hands during prolonged procedures.
Handheld Surgical Instruments Market Dynamics
Drivers
- Rising Surgical Procedures
Rising surgical procedures are a significant driver of the handheld surgical instruments market, fueled by the increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular disorders. According to the World Health Organization (WHO), non-communicable diseases are expected to account for 73% of global deaths by 2030, leading to a higher demand for surgical interventions. For instance, the American College of Surgeons reported a steady increase in surgical procedures, with over 51 million surgeries performed annually in the U.S. alone. This trend highlights the urgent need for effective surgical tools, as healthcare providers require reliable handheld instruments to address the growing volume of operations. Consequently, the demand for various handheld surgical instruments, including scalpels, forceps, and scissors, is expected to rise in tandem with the increasing number of surgical procedures, driving market growth significantly.
- Rising Healthcare Infrastructure Investments
Healthcare infrastructure investments are a vital driver of the handheld surgical instruments market, particularly as countries in emerging markets allocate more resources toward enhancing their healthcare systems. For instance, according to the WHO global spending on health continually rose between 2000 and 2018 and reached USD 8.3 trillion or 10% of global GDP, with substantial growth occurring in developing regions. Countries such as India and China are significantly increasing their healthcare budgets, with India projected to increase its healthcare expenditure to approximately 2.5% of its GDP by 2025. This surge in investment facilitates the procurement of advanced surgical instruments and the development of modern surgical facilities, thereby improving surgical capabilities and outcomes. As healthcare institutions expand their offerings and strive to meet international standards, the demand for high-quality handheld surgical instruments is set to rise, further driving market growth in these regions. This expansion enhances access to surgical care and underscores the importance of reliable surgical tools in achieving better health outcomes.
Opportunities
- Growing Preference for Minimally Invasive Surgery
The growing preference for minimally invasive surgery (MIS) techniques represents a significant market opportunity for handheld surgical instruments, as these procedures are increasingly favored for their numerous advantages, including reduced recovery times, less postoperative pain, and smaller incisions. According to a report by the National Institutes of Health, minimally invasive procedures have seen a dramatic rise, with laparoscopic surgeries becoming commonplace in various fields such as gynecology, urology, and general surgery. For instance, laparoscopic cholecystectomy, a minimally invasive procedure for gallbladder removal, is performed on over 800,000 patients in the U.S. each year. This shift towards MIS necessitates the use of specialized handheld instruments, such as graspers, scissors, and retractors, designed specifically for these techniques. As surgical centers continue to adopt MIS for a broader range of procedures, the demand for advanced handheld surgical instruments is expected to grow, creating significant opportunities for manufacturers to innovate and expand their product offerings in this evolving market landscape.
- Rising Cases of Road Accidents
The rising cases of road accidents present a significant market opportunity for the handheld surgical instruments sector, as these incidents often lead to trauma-related surgeries that require a wide range of surgical tools. According to the World Health Organization, approximately 1.35 million people die each year due to road traffic crashes, with many more suffering from serious injuries that necessitate surgical intervention. For instance, in the United States alone, the National Highway Traffic Safety Administration reported that there were over 38,000 fatalities and millions of injuries from road accidents in a recent year. This alarming trend underscores the need for efficient surgical procedures to address trauma cases, resulting in heightened demand for handheld surgical instruments such as scalpels, forceps, and suturing devices specifically designed for emergency and trauma surgeries. As healthcare providers respond to the increasing number of trauma cases stemming from road accidents, the market for handheld surgical instruments is poised for growth, offering manufacturers the chance to develop and supply advanced tools tailored for urgent care scenarios.
Restraints/Challenges
- Stringent Safety and Efficacy Standards
Regulatory compliance presents a significant challenge in the handheld surgical instruments market, as manufacturers must navigate complex approval processes to ensure their products meet stringent safety and efficacy standards. For instance, in the U.S., the FDA mandates that handheld surgical instruments, such as scalpels and forceps, undergo a rigorous premarket approval (PMA) process if they are classified as Class III devices. This involves extensive clinical testing, detailed documentation of manufacturing practices, and adherence to specific design controls, which can take several months or even years to complete and incurs substantial costs. Similarly, in Europe, the new Medical Device Regulation (MDR) requires surgical instrument manufacturers to conduct thorough clinical evaluations and ensure compliance with stricter safety requirements, which may lead to significant delays in product launch. This intricate regulatory landscape hampers the speed of innovation and places financial strain on manufacturers, ultimately affecting their competitive positioning in the handheld surgical instruments market.
- Training and Adoption
Training and adoption of new handheld surgical instruments present a significant challenge in the market, as the successful implementation of innovative technologies often requires specialized training for surgeons and medical staff. This necessity can lead to resistance among healthcare providers who may prefer to stick with familiar instruments and techniques, fearing that the learning curve associated with new tools could disrupt surgical workflows or negatively impact patient outcomes. For instance, the introduction of advanced surgical staplers that offer improved precision and efficiency necessitates comprehensive training sessions for operating room teams. Despite the benefits, many surgeons may hesitate to adopt these new devices due to concerns about the time required for training and the potential for complications during the transition period. Such resistance hinders the growth of the handheld surgical instruments market and limits the potential improvements in surgical outcomes that could result from these advancements.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Handheld Surgical Instruments Market Scope
The market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Application
- Neurosurgery
- Cardiovascular
- Orthopaedic
- Plastic and Reconstructive Surgery
- Obstetrics and Gynaecology
- Wound Care
- Audiology
- Thoracic Surgery
- Urology
- Others
End User
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
Handheld Surgical Instruments Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, product, application, and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America holds the largest share and revenue in the handheld surgical instruments market and is expected to maintain its leading position throughout the forecast period. This dominance is attributed to the region's advanced healthcare infrastructure, which supports the adoption of high-quality surgical tools. Additionally, the growing prevalence of chronic diseases such as cardiovascular disorders and cancer is driving demand for these instruments. With well-established healthcare facilities and a focus on advanced medical care, North America remains a key market for handheld surgical instruments.
Asia-Pacific is anticipated to show the fastest growth in the handheld surgical instruments market over the forecast period. This rapid expansion is driven by an aging population that requires more medical care, alongside increasing investments in healthcare infrastructure across the region. Additionally, demand for microsurgeries is rising, further propelling market growth as healthcare systems strive to meet advanced surgical needs. These factors position Asia-Pacific as a significant growth market in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Handheld Surgical Instruments Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Handheld Surgical Instruments Market Leaders Operating in the Market Are:
- Bausch Health Companies Inc. (Canada)
- B. Braun SE (Germany)
- Biotronik (Germany)
- Medtronic (Ireland)
- BD (U.S.)
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- Integra LifeSciences Corporation (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Zimmer Biomet (U.S.)
- CooperSurgical, Inc. (U.S.)
- Smith+Nephew (U.K.)
- TOPCON CORPORATION (Japan)
- Novartis AG (Switzerland)
- Danaher (U.S.)
- Aspen Surgical Products, Inc. (U.S.)
- Thompson Surgical (U.S.)
- KLS Martin Group (Germany)
Latest Developments in Handheld Surgical Instruments Market
- In June 2023, Becton Dickinson and Company signed an agreement with STERIS to divest its Surgical Instrumentation platform, simplifying its product range. This move allows Becton Dickinson to focus on priority business areas, while STERIS strengthens its surgical offerings
- In October 2022, Aspen Surgical acquired Symmetry Surgical, a key player in the production of specialty and high-quality surgical instruments. This acquisition boosts Aspen’s instrument portfolio, enabling it to provide a wider array of tools for surgical procedures
- In July 2022, Medtronic plc formed a strategic partnership with CathWorks, an Israeli company focused on coronary artery disease (CAD) diagnostics and therapy innovation. The collaboration aims to advance CAD surgical options and enhance patient outcomes
- In May 2022, Johnson & Johnson secured FDA approval for its Monarch robotic surgery system, which can now be used to assist in kidney stone removal. This approval marks an expansion in Johnson & Johnson’s robotic capabilities in minimally invasive surgery
- In May 2022, Medtronic plc completed the acquisition of Intersect ENT, integrating advanced sinus treatment devices into its ENT portfolio. This addition provides Medtronic with new tools to enhance post-operative outcomes and treat nasal polyps
SKU-